Roswell Park Cancer Institute /ID# 217857 — Buffalo, New York

Roswell Park Cancer Institute /ID# 217857 is a clinical research site located in Buffalo, New York, United States 14263.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

Roswell Park Cancer Institute /ID# 217857 has participated in 1 clinical trials.

Therapeutic areas: Acute Myeloid Leukemia (AML), Cancer.

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Roswell Park Cancer Institute /ID# 217857?

Roswell Park Cancer Institute /ID# 217857 has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Roswell Park Cancer Institute /ID# 217857 conducted?

Roswell Park Cancer Institute /ID# 217857 has 1 clinical trials on record. Their work covers Acute Myeloid Leukemia (AML), Cancer.

Is Roswell Park Cancer Institute /ID# 217857 accredited by Crixeo Health?

Roswell Park Cancer Institute /ID# 217857 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Roswell Park Cancer Institute /ID# 217857?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.